ATE335468T1 - Liposomzusammensetzung von 6,9-bis- (2- - Google Patents

Liposomzusammensetzung von 6,9-bis- (2-

Info

Publication number
ATE335468T1
ATE335468T1 AT00977418T AT00977418T ATE335468T1 AT E335468 T1 ATE335468 T1 AT E335468T1 AT 00977418 T AT00977418 T AT 00977418T AT 00977418 T AT00977418 T AT 00977418T AT E335468 T1 ATE335468 T1 AT E335468T1
Authority
AT
Austria
Prior art keywords
bis
liposome composition
liposome
isoquinoline
aminoethyl
Prior art date
Application number
AT00977418T
Other languages
English (en)
Inventor
Carlo Bugatti
Original Assignee
Cell Therapeutics Europe Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Therapeutics Europe Srl filed Critical Cell Therapeutics Europe Srl
Application granted granted Critical
Publication of ATE335468T1 publication Critical patent/ATE335468T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00977418T 1999-10-22 2000-10-19 Liposomzusammensetzung von 6,9-bis- (2- ATE335468T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI002219A IT1315253B1 (it) 1999-10-22 1999-10-22 Preparazione liposomiale di 6,9-bis-(2-amminoetil)ammino|benzog|isochinolin-5,10-dione dimaleato

Publications (1)

Publication Number Publication Date
ATE335468T1 true ATE335468T1 (de) 2006-09-15

Family

ID=11383836

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00977418T ATE335468T1 (de) 1999-10-22 2000-10-19 Liposomzusammensetzung von 6,9-bis- (2-

Country Status (23)

Country Link
US (1) US7449197B2 (de)
EP (1) EP1221940B1 (de)
JP (1) JP2003512313A (de)
KR (1) KR20020063880A (de)
CN (1) CN1164261C (de)
AT (1) ATE335468T1 (de)
AU (1) AU772339B2 (de)
BR (1) BR0014881A (de)
CA (1) CA2386143A1 (de)
CZ (1) CZ20021388A3 (de)
DE (1) DE60029979T2 (de)
EA (1) EA004477B1 (de)
ES (1) ES2269200T3 (de)
HU (1) HUP0203473A3 (de)
IL (2) IL149212A0 (de)
IT (1) IT1315253B1 (de)
MX (1) MXPA02003939A (de)
NO (1) NO20021867L (de)
NZ (1) NZ518005A (de)
PL (1) PL197412B1 (de)
SK (1) SK284247B6 (de)
WO (1) WO2001028521A2 (de)
ZA (1) ZA200203128B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2353593A1 (en) * 1998-12-18 2000-06-22 Hadasit Medical Research Services & Development Ltd. Method of administering a compound to multi-drug resistant cells
ITMI20021040A1 (it) 2002-05-16 2003-11-17 Novuspharma Spa Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale
CN1305881C (zh) * 2004-08-13 2007-03-21 河南工业大学 磷脂酰胆碱的制备方法
CN103479578B (zh) * 2012-06-14 2016-08-03 沈阳药科大学 一种马来酸匹杉琼的脂质体制剂及其制备工艺
CN105596295B (zh) * 2016-01-25 2018-03-16 北京博恩特药业有限公司 马来酸匹杉琼脂质体及其制备方法
CN105997896B (zh) * 2016-05-28 2019-07-05 长沙秋点兵信息科技有限公司 治疗非霍奇金淋巴瘤的注射用冻干粉及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
JPS6442418A (en) * 1985-12-06 1989-02-14 Yissum Res Dev Co Liposome/anthraquinone drug composition and therapy therewith
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
ES2072223B1 (es) * 1993-11-25 1996-03-16 Lipotec Sa Liposomas encapsulando doxorubicina.
CA2184834A1 (en) * 1994-03-11 1995-09-14 Yoshiyuki Mori Liposome preparation
US5587382A (en) * 1994-03-28 1996-12-24 Boehringer Mannheim Italia, Spa 6,9-bis[(2-aminoethyl) amino]benzo [g]isoquinoline-5,10- dione dimaleate; an aza-anthracenedione with reduced cardiotoxicity
US5506232A (en) * 1994-03-28 1996-04-09 Boehringer Mannheim Italia S.P.A. 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt
WO1999011242A1 (en) * 1997-09-04 1999-03-11 Biozone Laboratories, Inc. Oral liposomal delivery system

Also Published As

Publication number Publication date
NZ518005A (en) 2003-10-31
PL197412B1 (pl) 2008-03-31
ITMI992219A1 (it) 2001-04-22
IT1315253B1 (it) 2003-02-03
WO2001028521A3 (en) 2002-04-25
CZ20021388A3 (cs) 2002-08-14
DE60029979T2 (de) 2007-02-22
US20060078607A1 (en) 2006-04-13
EA200200389A1 (ru) 2002-08-29
HUP0203473A2 (hu) 2003-02-28
SK284247B6 (sk) 2004-12-01
PL354610A1 (en) 2004-02-09
CA2386143A1 (en) 2001-04-26
BR0014881A (pt) 2002-06-11
EP1221940B1 (de) 2006-08-09
CN1164261C (zh) 2004-09-01
ZA200203128B (en) 2003-06-05
EP1221940A2 (de) 2002-07-17
MXPA02003939A (es) 2004-06-25
NO20021867D0 (no) 2002-04-19
SK5382002A3 (en) 2002-09-10
KR20020063880A (ko) 2002-08-05
JP2003512313A (ja) 2003-04-02
IL149212A0 (en) 2002-11-10
IL149212A (en) 2006-12-10
US7449197B2 (en) 2008-11-11
DE60029979D1 (de) 2006-09-21
EA004477B1 (ru) 2004-04-29
AU772339B2 (en) 2004-04-22
AU1514601A (en) 2001-04-30
CN1382039A (zh) 2002-11-27
HUP0203473A3 (en) 2003-12-29
WO2001028521A2 (en) 2001-04-26
NO20021867L (no) 2002-04-19
ES2269200T3 (es) 2007-04-01

Similar Documents

Publication Publication Date Title
HK1047575A1 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same.
YU84703A (sh) Oralni rastvor aripiprazola
HUP9802221A2 (hu) Parazitaellenes hatású markfortin- és paraherkvamidszármazékok
RS50485B (sr) Terapeutske kombinacije koje sadrže amplodipin i atorvastatin
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
EE04275B1 (et) Kinoliini derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutilised kompositsioonid
IL138969A0 (en) Anthranilic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
BR9711311B1 (pt) derivado de 1,2,3,4-tetrahidroquinolina, composiÇço farmaceutica, uso de um derivado de 1,2,3,4-tetrahidroquinolina, e, processo para a preparaÇço de compostos.
EE03663B1 (et) Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine
SE8904298D0 (sv) New compounds
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
NO985145D0 (no) Farmas°ytiske preparater for forsinket frigj°ring av uoppl°selige, aktive bestanddeler
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
ATE335468T1 (de) Liposomzusammensetzung von 6,9-bis- (2-
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
BR9812085A (pt) "método para a sìntese de derivados de quinolina"
EP0842663A4 (de) Ophtalmika
EP0261524A3 (de) Arzneimittelzubereitungen
PT989994E (pt) Derivados de estreptograminas, a sua preparacao e as composicoes que os contem
EE05401B1 (et) Imidasolidiini derivaadid, nende valmistamine ja kasutamine p?letikuvastaste toimeainetena ning neid sisaldav ravimpreparaat
UY25592A1 (es) Derivados de ciclohexano condensados con quinolina
KR970006264A (ko) 신규한 6-치환-5, 8-디옥시-1, 4-나프토퀴논 유도체, 그의 제조방법 및 그의 항암제로서의 용도
PT796256E (pt) Novos processos de preparacao da ranitidina
TR200302031T4 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin'ler ve farmasotik preparat olarak kullanımları
FI945414A0 (fi) Menetelmä N,N-disubstituoidun aminofenolin valmistamiseksi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties